![Samir Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samir Patel
President at
PEAK BIO, INC.
Net worth: 63 473 $ as of 31/05/2025
Profile
Dr. Samir R.
Patel, MD, is a President & Secretary at Peak Bio, Inc., a Chief Executive Officer at Digital Therapeutics LLC, a President, Secretary & Director at Pegasus Merger Sub, Inc., a Principal at Pranabio Investments LLC and a Principal at SPEC Pharma LLC.
He is on the Board of Directors at Akari Therapeutics Plc and Pegasus Merger Sub, Inc. Dr. Patel was previously employed as an Independent Director by CytoDyn, Inc., an Independent Director by Rezolute, Inc., and a Medical Affairs by Centocor, Inc. He received his undergraduate degree from the University of Cincinnati (Ohio) and a doctorate degree from the University of Toledo Medical Center.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AKARI THERAPEUTICS PLC 11.93% | 01/06/2026 | 6,347,346,000 ( 11.93% ) | 63 473 $ | 31/05/2025 |
Samir Patel active positions
| Companies | Position | Start |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Director/Board Member | 29/11/2023 |
| PEAK BIO, INC. | President | 14/11/2024 |
SPEC Pharma LLC
 SPEC Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which specializes in injectable therapies | Founder | - |
Digital Therapeutics LLC
 Digital Therapeutics LLC Packaged SoftwareTechnology Services Develops application for personalized and gamified cognitive behavioral therapy to smokers trying to quit | Chief Executive Officer | 01/08/2011 |
Pranabio Investments LLC
 Pranabio Investments LLC Financial ConglomeratesFinance Provides investment services | Founder | - |
Pegasus Merger Sub, Inc. | President | - |
Former positions of Samir Patel
| Companies | Position | End |
|---|---|---|
| CYTODYN INC. | Director/Board Member | 28/10/2021 |
| REZOLUTE, INC. | Director/Board Member | 10/02/2019 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Chief Tech/Sci/R&D Officer | - |
Training of Samir Patel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toledo Medical Center
 University of Toledo Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Pranabio Investments LLC
Pranabio Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
SPEC Pharma LLC
SPEC Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which specializes in injectable therapies | Health Technology |
Digital Therapeutics LLC
Digital Therapeutics LLC Packaged SoftwareTechnology Services Develops application for personalized and gamified cognitive behavioral therapy to smokers trying to quit | Technology Services |
Peak Bio, Inc.
 Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
Pegasus Merger Sub, Inc. |
- Stock Market
- Insiders
- Samir Patel
Choose MarketScreener 
